Search PubMedSearch

Biomedical subjects

T R Kessler

Publications and source records attributed to T R Kessler.

16 recordsLinked to original sources

Retrieval and analysis of a clinical total artificial heart.

Examination by light microscopy, scanning electron microscopy (SEM), and x-ray microanalysis of a clinical total artificial heart (TAH) implanted for 112 days revealed no evidence of calcification, pannus, or vegetative thrombus. A macroscopic thrombus was seen along the suture line in the right atrium but did not obstruct blood flow or valve function. Microscopic thrombi (less than 0.1 mm) and evidence of microemboli were observed on the pumping diaphragm using SEM. Characterization of selected polyetherurethane (PEU) samples from the pumping bladders and housing by Curie-point pyrolysis mass spectrometry (Py-MS) revealed unexpected differences between postmortem retrieved ventricles. Although the origin of these differences could be traced back to batch-to-batch variations in the original PEU material (Biomer), the precise nature of the observed differences in chemical structure and/or composition is still unknown. Numerical comparison between pyrolysis mass spectra from PEU samples exposed to blood or tissue and unexposed samples from the same ventricles did not detect evidence of biodegradation. Continual improvements in fabrication and quality control should minimize surface imperfections and ensure polymer reproducibility; however, existing materials and design parameters appear to be adequate for continued clinical implantation.

Electron Probe Microanalysis

A seven-month survival of a calf with an artificial heart designed for human use.

A Jarvik-7 type of pneumatic artificial heart, which was specifically designed to fit the anatomy and hemodynamic requirements of human patients, was implanted in a calf in an experiment to test the hemodynamic performance of the artificial heart. The experiment lasted for 221 days, longer than any animal had ever lived without its natural heart, despite the fact that the calf increased its body weight to 171 kg. The calf showed typical signs of low cardiac output before its death, but the direct cause of death was intestinal bleeding. At autopsy, it was discovered that the low cardiac output was due to severe pannus around the left inflow valve, as diagnosed earlier by changes in the pneumatic pressure wave form.

Animals

Determinants of pannus formation in long-surviving artificial heart calves, and its prevention.

In a group of 76 calves maintained with Jarvik-5 and Jarvik-7 artificial hearts, pannus formation in the atrial location was evaluated retrospectively using a grading system based on measurement of the pannus tissue. Pannus was present in 87% of the calves surviving one to 7 mos with an old-style inflow quick-connect design utilizing polyester felt surfaces. This design had a suboptimal hemodynamic flow path. Using a new design of quick-connect with an improved hemodynamic flow path and a Biomer blood-contacting surface, pannus occurred only in 17% of calves surviving one to 9 mos. Furthermore, the pannus formation with the new design was mild in the 2 cases where it occurred, whereas the pannus formation in animals with the old cuffs was frequently severe. One calf survived 9 mos with no pannus formation utilizing our new quick-connect system, and we conclude that pannus is no longer a problem in our experiments. We also reviewed the relation of pannus to anticoagulant regimens and found that Persantine, Coumadin, and aspirin were not effective in preventing pannus when the inflow cuff design was conducive to its development.

Animals

Six-month survival of a calf with an artificial heart.

A pneumatically powered artificial heart, constructed primarily from a polyurethane, was implanted in the chest of a calf and supported the calf for more than 6 months. The heart, which was designed to fit in the chest of a 90 kilogram calf, was able to suppor the animal when it weighed 180 kilograms. During the first 105 days the calf remained strong and healthy. The animal grew progressively weaker after day 106, and by day 160 right heart failure became apparent. The principal cause of the right heart failure was an obstructive growth between the right atrium and the right ventricle. An attempt to correct the problem on day 184 with an artificial heart resulted in the animal's death.

Animals

The role of cardiac valves in artificial heart performance.

The criteria for the design, selection of materials, and fabrication of a total artificial heart have evolved over several years. As these criteria have become more sophisticated and exact, they have optimized the performance of all components within the system. A pump with sufficient volume and pressure output that fits in the available anatomic space was a primary objective. Concomitantly, a nonthrombogenic, durable material that was nondegradable in body fluids was being developed. The most easily managed energy source selected to date has been pulsed, compressed air programmed for gentle but effective systole and diastole. The evolution of good cardiac valves has been of major importance to the artificial heart effort. The historical development of the artificial heart has often centered around existing prosthetic valves which are currently an integral component of the complete system. A detailed analysis of the performance of the total artificial heart clearly identifies the role of the cardiac valve.

Animals